🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 18 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/03/2011 6,15 6,30 6,10 6,20 +1,64% 3,25% 14.770
18/03/2011 6,00 6,20 6,00 6,10 +1,67% 3,33% 13.440
17/03/2011 6,10 6,15 6,00 6,00 -1,64% 2,46% 19.030
16/03/2011 6,30 6,30 6,10 6,10 -2,56% 3,17% 27.710
15/03/2011 6,30 6,37 6,26 6,26 -2,19% 1,75% 11.110
14/03/2011 6,50 6,50 6,26 6,40 -1,54% 3,69% 16.330
11/03/2011 6,60 6,70 6,40 6,50 -2,99% 4,55% 11.380
10/03/2011 7,00 7,00 6,60 6,70 -2,90% 5,71% 12.950
09/03/2011 6,90 7,00 6,65 6,90 +2,99% 5,07% 14.080
08/03/2011 6,60 6,71 6,47 6,70 +1,52% 3,64% 16.730
07/03/2011 6,81 6,81 6,60 6,60 -2,94% 3,08% 13.420
04/03/2011 6,40 6,90 6,40 6,80 +4,62% 7,81% 11.640
03/03/2011 6,56 6,70 6,41 6,50 -1,52% 4,42% 43.480
02/03/2011 6,60 6,70 6,56 6,60 +0,00% 2,12% 22.230
01/03/2011 6,81 7,00 6,40 6,60 -2,94% 8,81% 44.600
28/02/2011 6,90 6,92 6,78 6,80 -1,45% 2,03% 23.480
25/02/2011 6,96 7,09 6,86 6,90 -0,86% 3,30% 14.470
24/02/2011 7,05 7,20 6,96 6,96 -1,28% 3,40% 15.320
23/02/2011 7,20 7,25 7,01 7,05 -0,98% 3,33% 10.870
22/02/2011 7,11 7,25 7,11 7,12 -0,84% 1,97% 17.210
18/02/2011 7,41 7,49 7,11 7,18 -1,64% 5,13% 20.580
17/02/2011 7,20 7,50 7,10 7,30 +0,00% 5,56% 21.430
16/02/2011 8,10 8,10 7,03 7,30 -9,54% 13,21% 134.460
15/02/2011 8,50 8,50 8,00 8,07 -5,06% 5,88% 34.960
14/02/2011 8,40 8,60 8,38 8,50 +1,19% 2,62% 5.510
11/02/2011 8,83 8,93 8,10 8,40 -5,62% 9,40% 45.560
10/02/2011 8,93 9,10 8,82 8,90 +0,00% 3,14% 13.930
09/02/2011 9,48 9,50 8,89 8,90 -3,26% 6,43% 16.270
08/02/2011 9,10 9,28 9,00 9,20 +2,22% 3,08% 10.250
07/02/2011 8,80 9,50 8,80 9,00 +1,12% 7,95% 45.460